"Centro de Estudios Clínicos, especializado en Oncología"

During the past decade, Centro de Estudios Clínicos SAGA conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro de Estudios Clínicos SAGA" are "Gastric Adenocarcinoma" (1 trials), "Hepatocellular Carcinoma" (1 trials), "NSCLC" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centro de Estudios Clínicos SAGA" in a lesser frequency.

Most popular intervention types in "Centro de Estudios Clínicos SAGA" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Alectinib" (1 trials), "Derazantinib" (1 trials), "Derazantinib-atezolizumab" (1 trials) and "Derazantinib-paclitaxel-ramucirumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Estudios Clínicos SAGA" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Estudios Clínicos SAGA". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro de Estudios Clínicos SAGA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Estudios Clínicos SAGA, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".